U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. International Activities
  4. Foreign Regulatory Seminar (Web-Based) - Regulatory Overview
  1. International Activities

Foreign Regulatory Seminar (Web-Based) - Regulatory Overview

FDA Laws, Regulations, and Guidance Documents

Discussion of the legal framework within which CBER operates; introduction to and historical overview of statutes relevant to CBER’s regulatory activities; FDA rulemaking; and FDA guidance documents.


Good Guidance Practices

Discussion of FDA’s development of draft and final guidance documents.


Product Jurisdiction

An overview of CBER’s decision process on regulatory responsibility for products within the Center.


CBER Advisory Committees

Overview of the FDA Advisory Committee Program, to include areas under advisement, committee structure, member screening, and public forums.


Addressing Pandemic Influenza Preparedness

Discussion of the 2009 H1N1 pandemic, and includes discussion on licensure of H1N1 vaccines, regulatory pathways for pandemic vaccine licensure, and emergency use authorizations.


Return to Foreign Regulatory Seminar (Web-Based)

Back to Top